Revance Therapeutics
Utility Patents

Last updated:

List of all Revance Therapeutics patents 3 in total

Status Patent
Grant
Utility: Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds External link
Filling date: 7 Sep 2025 Issue date: 8 Dec 2020
Grant
Utility: Compositions and methods for topical application and transdermal delivery of botulinum toxins External link
Filling date: 7 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Botulinum toxin and the treatment of primary disorders of mood and affect External link
Filling date: 7 Sep 2025 Issue date: 15 Oct 2019

Showing 1 to 3 of 3 patents.